Odyssey Health, Inc.
For the period ended Jan 31, 2025. Filed Mar 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2025 · Filed Mar 14, 2025
ODYYStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| January 31, | July 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash | $7,187 | $2,379 |
| Research and development rebate due from Australian government | – | 22,625 |
| Prepaid expenses and other current assets | 101,174 | 31,939 |
| Total current assets | 108,361 | 56,943 |
| Investment | 158,505 | 529,203 |
| Total assets | $266,866 | $586,146 |
| Liabilities and Stockholders' Deficit | ||
| Current liabilities: | ||
| Accounts payable | $1,452,794 | $1,275,996 |
| Accrued wages | 1,864,463 | 1,648,586 |
| Accrued interest | 322,382 | 223,754 |
| Asset purchase liability | 1,125,026 | 1,125,026 |
| Notes payable, officers and directors | 100,000 | 100,000 |
| Notes payable, net of unamortized debt discount and closing costs of $19,646 and $38,134 | 1,865,021 | 1,546,533 |
| Total current liabilities | 6,729,686 | 5,919,895 |
| Commitments and contingencies | – | – |
| Stockholders' deficit: | ||
| Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued or outstanding | – | – |
| Common stock, $0.001 par value, 500,000,000 shares authorized, 96,709,763 and 96,709,763 shares issued and outstanding | 96,710 | 96,710 |
| Additional paid-in-capital | 55,682,648 | 55,572,687 |
| Accumulated deficit | (62,242,178) | (61,003,146) |
| Total stockholders' deficit | (6,462,820) | (5,333,749) |
| Total liabilities and stockholders' deficit | $266,866 | $586,146 |
*The accompanying notes are an integral part of these condensed consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.